 BeiGene stock popped Wednesday after the companys leukemia treatment beat out a blockbuster drug from Johnson Johnson. The post BeiGene Takes On Johnson Johnsons Blockbuster Cancer Drug And Wins appeared first on Investors Business Daily. 